共 185 条
[1]
Kyle RA(1986)Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases Blood 68 220-224
[2]
Greipp PR(2007)The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology J Am Coll Cardiol 50 1914-1931
[3]
O’Fallon WM(2005)Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 111 122-124
[4]
Cooper LT(2006)MR findings in cardiac amyloidosis AJR Am J Roentgenol 186 1682-1685
[5]
Baughman KL(2008)Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy J Am Coll Cardiol 51 1022-1030
[6]
Feldman AM(2003)Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study Lancet 361 374-379
[7]
Frustaci A(2010)Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis JACC Cardiovasc Imaging 3 155-164
[8]
Jessup M(2005)Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies Eur Heart J 26 1461-1474
[9]
Kuhl U(2003)Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 1561-1567
[10]
Levine GN(2002)Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy Tex Heart Inst J 29 176-180